Table 4.

Progression-free survival after firstline chemotherapy.

	Characteristic	Median (95% CI; months)	P
General		7.66 (4.7–10.5)
Gender	Male	7.33 (3.6–10.9)	0.314
	Female	7.76 (2.7–12.7)
Chemotherapy	Yes	7.76 (3.6–11.8)	0.572
	No	6.57 (1.3–11.8)